Skip to main content
Fig. 3 | Stem Cell Research & Therapy

Fig. 3

From: Plasma proteomics-based biomarkers for predicting response to mesenchymal stem cell therapy in severe COVID-19

Fig. 3

Thirteen differentially expressed proteins (DEPs) and their functional enrichment analysis between the responders and non-responders pre-MSC treatment. A Heatmap showing 13 differentially expressed proteins between the responders and non-responders. B The red dots represent the upregulated DEPs based on p < 0.05 and fold change (FC) > 1.5, and the blue dots represent downregulated DEPs based on p < 0.05 and FC < 1/1.5. The gray spots represent proteins with no significant difference. C GO-based enrichment analysis of DEPs in terms of biological processes (hypergeometric test; p < 0.05). GO terms were sorted according to p

Back to article page